APP and Alzheimer disease: Similarly, data from other experiments also verified that delivering miR-132 synthetic agents into the brains of diverse rodent AD models (such as APP/PS1 and 3xTg AD mice) could alleviate the accumulation of Aβ 40–42 and Tau hyperphosphorylation and restore hippocampal neurogenesis and cognitive function [343, 344].